GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (MEX:0QBO) » Definitions » Earnings per Share (Diluted)

Coloplast AS (MEX:0QBO) Earnings per Share (Diluted) : MXN55.45 (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Coloplast AS Earnings per Share (Diluted)?

Coloplast AS's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was MXN14.96. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was MXN55.45.

Coloplast AS's EPS (Basic) for the three months ended in Jun. 2024 was MXN14.96. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was MXN55.45.

Coloplast AS's EPS without NRI for the three months ended in Jun. 2024 was MXN15.30. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was MXN56.71.

During the past 12 months, Coloplast AS's average EPS without NRIGrowth Rate was -0.30% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 4.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.00% per year.

During the past 13 years, Coloplast AS's highest 3-Year average EPS without NRI Growth Rate was 56.10% per year. The lowest was -9.80% per year. And the median was 8.90% per year.


Coloplast AS Earnings per Share (Diluted) Historical Data

The historical data trend for Coloplast AS's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Earnings per Share (Diluted) Chart

Coloplast AS Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.95 68.81 73.62 59.17 55.34

Coloplast AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.92 13.64 13.39 13.48 14.96

Competitive Comparison of Coloplast AS's Earnings per Share (Diluted)

For the Medical Instruments & Supplies subindustry, Coloplast AS's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's PE Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's PE Ratio falls into.



Coloplast AS Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Coloplast AS's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (A: Sep. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(11923.034-0)/215.500
=55.33

Coloplast AS's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2024 is calculated as

Diluted Earnings Per Share (Q: Jun. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(3366.189-0)/224.800
=14.97

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN55.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Coloplast AS  (MEX:0QBO) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Coloplast AS Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines